1. There was no significant difference in periprocedural myonecrosis between ticagrelor and clopidogrel among patients undergoing high-risk elective PCI.
2. Ticagrelor treatment was associated with an increased rate of minor bleeding at 30 days post-operation.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Percutaneous coronary intervention (PCI) provides a safe therapeutic option for patients with...